Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Life course body mass index and risk and prognosis of amyotrophic lateral sclerosis: results from the ALS registry Swabia
Raphael S. Peter, Angela Rosenbohm, Luc Dupuis, et al.
European Journal of Epidemiology (2017) Vol. 32, Iss. 10, pp. 901-908
Closed Access | Times Cited: 97

Showing 1-25 of 97 citing articles:

Energy metabolism in ALS: an underappreciated opportunity?
Tijs Vandoorne, Katrien De Bock, Ludo Van Den Bosch
Acta Neuropathologica (2018) Vol. 135, Iss. 4, pp. 489-509
Open Access | Times Cited: 220
Effect of High‐Caloric Nutrition on Survival in Amyotrophic Lateral Sclerosis
Albert C. Ludolph, Johannes Dorst, Jens Dreyhaupt, et al.
Annals of Neurology (2019) Vol. 87, Iss. 2, pp. 206-216
Closed Access | Times Cited: 146
Hypothalamic Alterations in Neurodegenerative Diseases and Their Relation to Abnormal Energy Metabolism
Pauline Vercruysse, Didier Vieau, David Blum, et al.
Frontiers in Molecular Neuroscience (2018) Vol. 11
Open Access | Times Cited: 147
Impact of expiratory strength training in amyotrophic lateral sclerosis: Results of a randomized, sham‐controlled trial
Emily K. Plowman, Lauren Tabor Gray, K. Michelle Rosado, et al.
Muscle & Nerve (2018) Vol. 59, Iss. 1, pp. 40-46
Closed Access | Times Cited: 109
Early weight loss in amyotrophic lateral sclerosis: outcome relevance and clinical correlates in a population-based cohort
Cristina Moglia, Andrea Calvo, Maurizio Grassano, et al.
Journal of Neurology Neurosurgery & Psychiatry (2019) Vol. 90, Iss. 6, pp. 666-673
Closed Access | Times Cited: 88
Tracking a Fast-Moving Disease: Longitudinal Markers, Monitoring, and Clinical Trial Endpoints in ALS
Rangariroyashe H. Chipika, Eoin Finegan, Stacey Li Hi Shing, et al.
Frontiers in Neurology (2019) Vol. 10
Open Access | Times Cited: 83
The current use of telehealth in ALS care and the barriers to and facilitators of implementation: a systematic review
Jochem Helleman, Esther T. Kruitwagen‐van Reenen, Leonard H. van den Berg, et al.
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration (2019) Vol. 21, Iss. 3-4, pp. 167-182
Open Access | Times Cited: 76
Nutritional and metabolic factors in amyotrophic lateral sclerosis
Albert C. Ludolph, Luc Dupuis, Edward J. Kasarskis, et al.
Nature Reviews Neurology (2023) Vol. 19, Iss. 9, pp. 511-524
Closed Access | Times Cited: 29
Metabolic alterations precede neurofilament changes in presymptomatic ALS gene carriers
Johannes Dorst, Patrick Weydt, Dávid Brenner, et al.
EBioMedicine (2023) Vol. 90, pp. 104521-104521
Open Access | Times Cited: 25
Mitochondria: A Promising Convergent Target for the Treatment of Amyotrophic Lateral Sclerosis
Teresa Cunha‐Oliveira, Liliana Montezinho, Rui F. Simões, et al.
Cells (2024) Vol. 13, Iss. 3, pp. 248-248
Open Access | Times Cited: 10
Skeletal muscle dysfunction in amyotrophic lateral sclerosis: a mitochondrial perspective and therapeutic approaches
Gökhan Burçin Kubat, Pasquale Picone
Neurological Sciences (2024) Vol. 45, Iss. 9, pp. 4121-4131
Open Access | Times Cited: 10
Early-onset sleep alterations found in patients with amyotrophic lateral sclerosis are ameliorated by orexin antagonist in mouse models
Simon J. Guillot, Christina Lang, Marie Simonot, et al.
Science Translational Medicine (2025) Vol. 17, Iss. 783
Closed Access | Times Cited: 1
Longitudinal Metabolomics in Amyotrophic Lateral Sclerosis Implicates Impaired Lipid Metabolism
Kai Guo, Masha G. Savelieff, Dae‐Gyu Jang, et al.
Annals of Neurology (2025)
Open Access | Times Cited: 1
Loss of appetite is associated with a loss of weight and fat mass in patients with amyotrophic lateral sclerosis
Shyuan T. Ngo, Ruben P.A. van Eijk, Veronique Chachay, et al.
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration (2019) Vol. 20, Iss. 7-8, pp. 497-505
Open Access | Times Cited: 56
High BMI is associated with low ALS risk
Ola Nakken, Helmut E. Meyer, Hein Stigum, et al.
Neurology (2019) Vol. 93, Iss. 5
Open Access | Times Cited: 56
Skeletal Muscle in ALS: An Unappreciated Therapeutic Opportunity?
Silvia Scaricamazza, I. Salvatori, Alberto Ferri, et al.
Cells (2021) Vol. 10, Iss. 3, pp. 525-525
Open Access | Times Cited: 53
Congenic expression of poly-GA but not poly-PR in mice triggers selective neuron loss and interferon responses found in C9orf72 ALS
Katherine D. LaClair, Qihui Zhou, Meike Michaelsen, et al.
Acta Neuropathologica (2020) Vol. 140, Iss. 2, pp. 121-142
Open Access | Times Cited: 52
Associations between lifestyle and amyotrophic lateral sclerosis stratified by C9orf72 genotype: a longitudinal, population-based, case-control study
Henk‐Jan Westeneng, Kevin van Veenhuijzen, Rick A. A. van der Spek, et al.
The Lancet Neurology (2021) Vol. 20, Iss. 5, pp. 373-384
Closed Access | Times Cited: 47
Evidence of Metabolic Dysfunction in Amyotrophic Lateral Sclerosis (ALS) Patients and Animal Models
Katarina Maksimovic, Mohieldin Youssef, Justin You, et al.
Biomolecules (2023) Vol. 13, Iss. 5, pp. 863-863
Open Access | Times Cited: 21
Association of blood lipids with onset and prognosis of amyotrophic lateral sclerosis: results from the ALS Swabia registry
Sebastian Michels, Deborah Kurz, Angela Rosenbohm, et al.
Journal of Neurology (2023) Vol. 270, Iss. 6, pp. 3082-3090
Open Access | Times Cited: 18
Lipids and amyotrophic lateral sclerosis: A two‐sample Mendelian randomization study
Kailin Xia, Veronika Klose, Josef Högel, et al.
European Journal of Neurology (2023) Vol. 30, Iss. 7, pp. 1899-1906
Open Access | Times Cited: 17
Metabolic Changes Associated With Muscle Expression of SOD1G93A
Gabriella Dobrowolny, Elisa Lepore, Martina Martini, et al.
Frontiers in Physiology (2018) Vol. 9
Open Access | Times Cited: 51
Sphingolipids metabolism alteration in the central nervous system: Amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases
Alexandra Bouscary, Cyril Quessada, Frédérique René, et al.
Seminars in Cell and Developmental Biology (2020) Vol. 112, pp. 82-91
Open Access | Times Cited: 41
Metabolic Dysfunction in Spinal Muscular Atrophy
Marc‐Olivier Deguise, Lucia Chehadé, Rashmi Kothary
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 5913-5913
Open Access | Times Cited: 37
Correlation of weight and body composition with disease progression rate in patients with amyotrophic lateral sclerosis
Jin-Yue Li, Xiaohan Sun, Zhengyi Cai, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 23
Page 1 - Next Page

Scroll to top